Trans-Pacific Aerospace Company Inc (OTCMKTS:TPAC) Moves Further Up

[[tagnumber 0]][[tagnumber 1]]The history of Trans–Pacific Aerospace Company Inc (OTCMKTS:TPAC) is very tragic. This is one of the reasons for which the company stock was crawling at rock bottom for the better part of the past few months.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]People who have been invested with the company for a long time know all about the massive problems surrounding it. One of these problems are the numbers that are contained in the balance sheet of [[tagnumber 6]]TPAC.[[tagnumber 7]] Here is just an example of some of those that we saw in the report covering the quarterly period ended January 31, 2015.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $36,304[[tagnumber 13]] [[tagnumber 12]]current assets: $40,262[[tagnumber 13]] [[tagnumber 12]]current liabilities: $912,841[[tagnumber 13]] [[tagnumber 12]]revenues: ZERO[[tagnumber 13]] [[tagnumber 12]]net loss: $1,620,872[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Nothing out of the ordinary for an OTC company, right? Well, yes actually, apart from the fact that the company should have generated at least some revenues according to press releases that were issued more than a year ago. Let’s not forget that, according to a press release issued on March 27, 2014, [[tagnumber 6]]TPAC[[tagnumber 7]] had received its first order for spherical bearings.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This means that we should be already seeing some revenues in their financial reports. Not to mention that, a few months later, the company announced another purchase order from a NYSE listed company. Still, we see no revenues in sight, but there is something even worse that is happening.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The dilution that [[tagnumber 6]]TPAC[[tagnumber 7]] shareholders have experienced is simply massive. As we wrote in our previous article, the company increased its authorized share count [[tagnumber 6]]from 150 million to a whopping 4.5 billion[[tagnumber 7]] in a matter of a few months. Meanwhile, the outstanding share count rose from under 200 million in March last year to around 500 million in March this year.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Somehow, company management thought it would be a great idea to issue even more share and the O/S count was sitting at [[tagnumber 6]]1.3 billion on April 23[[tagnumber 7]]. By now, the number of issued and outstanding shares listed in the OTC markets profile of [[tagnumber 6]]TPAC[[tagnumber 7]] has risen to [[tagnumber 6]]2.4 billion[[tagnumber 7]]. It all seems rather strange that the company stock has managed to lift itself from the ground lately.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Considering the stunning disregard for shareholder value, the press releases filled with empty promises and the horrid financials of [[tagnumber 6]]TPAC[[tagnumber 7]] we can’t help but feel like this is one of the most terrible investment choices over at the OTC marketplace. If you do, however, have any intentions of making a play, you should be sure to do your due diligence, weigh out the risks and brace for the worst.[[tagnumber 2]]